Combined approach in ventricular septal defect and adult pulmonary hypertension
Faruk Cingoz1, Murat Tavlasoglu, Mehmet Ali Sahin
1Department of Cardiovascular Surgery, Gulhane Military Medical Academy, Ankara, Turkey.
Insights
Early closure of large ventricular septal defects is crucial. This case study shows successful pulmonary hypertension treatment in an adult after VSD closure using inhaled nitric oxide, sildenafil, and bosentan.
Area of Science:
- Cardiology
- Pulmonology
- Adult Congenital Heart Disease
Background:
- Early closure of large ventricular septal defects (VSDs) is critical to prevent elevated pulmonary vascular resistance.
- Pulmonary hypertension can lead to significant morbidity and mortality, even after late VSD closure.
Observation:
- A 25-year-old woman presented with pulmonary hypertension following the surgical closure of a large VSD.
- The patient's condition required intensive management to address the post-surgical pulmonary hypertensive event.
Findings:
- Successful treatment of severe pulmonary hypertension was achieved using a combination of inhaled nitric oxide, sildenafil, and bosentan.
- This multi-drug approach effectively managed the pulmonary hypertensive crisis in the adult patient.
Implications:
- Post-operative pulmonary hypertension management is a key factor influencing prognosis in adult VSD closure patients.
- This case highlights the potential efficacy of inhaled nitric oxide, sildenafil, and bosentan in treating refractory pulmonary hypertension after VSD repair.
Abstract:
Early closure of a large ventricular septal defect before the onset of elevated pulmonary vascular resistance is important. Pulmonary hypertensive events might cause significant morbidity or mortality, even when closure is performed after infancy. Therefore, treatment of pulmonary hypertension after surgery may be the most important issue affecting the prognosis. We describe successful treatment of pulmonary hypertension in a 25-year-old woman after closure of large ventricular septal defect, with inhaled nitric oxide, sildenafil, and bosentan.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Mitral Stenosis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Mitral Regurgitation III: Medical Management
Aortic Regurgitation III: Medical Management
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...


